NOEVIR 5 TREATMENT LIQUID FOUNDATION LX

Manufacturer: NOEVIR USA INC | NOEVIR CO Ltd
Effective date: 2010-08-01
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 22:25:24

Label at a glance#

ProductNOEVIR 5 TREATMENT LIQUID FOUNDATION LX

Active ingredientOCTINOXATE, TITANIUM DIOXIDE

Label structure2 sections

Label contents#

Full prescribing information#

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Drug Facts
Active Ingredients                       Purpose
OCTINOXATE 1%                   Sunscreen
TITANIUM DIOXIDE 7.49%         Sunscreen

Uses

Helps prevent sunburn.
Higher SPF gives more sunburn protection.
Provides high protection against sunburn.

Warnings
For external use only.
When using this product

Keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if

Rash or irritation develops and lasts.

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away.

Directions
Apply a thin, even layer. For full coverage, apply additional layers.

Apply evenly before sun exposure.
Children under 6 months of age ask a doctor.
Reapply as needed or after towel drying, swimming or sweating.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
62908-013-02	2019-10-21	C162847	48780-1	956f9ecf-d146-621f-e053-dbdaa90a74ad	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
62908-013-01	NOEVIR 5 TREATMENT LIQUID FOUNDATION LX	38 g in 1 TUBE	LIQUID	38		1
62908-013-02	NOEVIR 5 TREATMENT LIQUID FOUNDATION LX	1 in 1 BOX	LIQUID	1		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
62908-013	NOEVIR 5 TREATMENT LIQUID FOUNDATION LX (OCTINOXATE, TITANIUM DIOXIDE) LIQUID [NOEVIR USA INC]	1	Legacy NDC, 2 package rows	20100801_cc17ad55-ae6a-4827-869a-923a7fd3deda.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	1
TITANIUM DIOXIDE	ACTIVE INGREDIENT	15FIX9V2JP	1
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	1
TITANIUM DIOXIDE	ACTIVE MOIETY	15FIX9V2JP	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NOEVIR 5 TREATMENT LIQUID FOUNDATION LX
OCTINOXATE, TITANIUM DIOXIDE
OCTINOXATE
TITANIUM DIOXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
62908-013	62908-013-01, 62908-013-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
OCTINOXATE	4Y5P7MUD51	ACTIB
TITANIUM DIOXIDE	15FIX9V2JP	ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
b919b1fd-74b9-4fee-ae43-ff87be7ed754			cc17ad55-ae6a-4827-869a-923a7fd3deda	2010-08-01		Exact identifier spl id: b919b1fd-74b9-4fee-ae43-ff87be7ed754 spl set id: cc17ad55-ae6a-4827-869a-923a7fd3deda

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.